More than a quarter of the years of healthy life lost to breast cancer globally are linked to preventable lifestyle factors, including diet and smoking, according to a comprehensive new analysis published in The Lancet Oncology. The study, which examined data from over 200 countries spanning 1990 to 2023, underscores the significant impact of modifiable risk factors on the burden of this disease and offers a crucial perspective on global breast cancer trends.
Researchers predict a concerning 33% rise in new breast cancer cases worldwide by 2050, climbing from 2.3 million in 2023 to over 3.5 million. This projected increase highlights the urgent need for preventative measures and improved access to care, particularly in low- and lower-middle-income countries where later-stage diagnoses and limited treatment options contribute to higher mortality rates. Understanding the factors driving this rise in breast cancer incidence is paramount to mitigating its impact.
Lifestyle Factors Play a Significant Role
The analysis revealed that approximately 28% of the global breast cancer burden – equivalent to 6.8 million years of healthy life lost in 2023 – is attributable to six key modifiable risk factors. High red meat consumption emerged as the most substantial contributor, linked to nearly 11% of all healthy life lost. Following closely behind was tobacco apply, including exposure to secondhand smoke, accounting for 8%. Other significant factors included high blood sugar (6%), high body mass index (4%), and both high alcohol consumption and low physical activity (2% each). These findings reinforce previous research, such as that conducted by Cancer Research UK, which indicated that over four in ten cancer cases in the UK are preventable through lifestyle changes.
Kayleigh Bhangdia, lead author of the study and researcher at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, emphasized the profound impact of breast cancer on women’s lives and communities. “While those in high-income countries typically benefit from screening and more timely diagnosis and comprehensive treatment strategies, the mounting burden of breast cancer is shifting to low- and lower middle-income countries where individuals often face later-stage diagnosis, more limited access to quality care and higher death rates that are threatening to eclipse progress in women’s health,” she stated.
Shifting Demographics and Rising Incidence in Younger Women
While breast cancer remains more prevalent in older women, the study revealed a notable trend: an almost 30% increase in new cases diagnosed in women aged 20 to 54 since 1990. In 2023, three times as many cases were diagnosed in women 55 and older (161 cases per 100,000 women) compared to those aged 20-54 (50 cases per 100,000 women). However, the accelerating rate of diagnoses in younger women warrants further investigation and could signal the influence of evolving lifestyle factors or other yet-unidentified causes. This rise in incidence among younger women underscores the importance of awareness and early detection across all age groups.
Advances in Treatment and the Promise of Partial-Breast Radiotherapy
Despite the projected increase in cases, advancements in treatment are offering hope. Recent research confirms that partial-breast radiotherapy is as safe and effective as whole-breast radiotherapy for low-risk early breast cancer patients. This approach, delivered with intensity-modulated radiotherapy, is now considered standard of care, potentially reducing treatment side effects and improving quality of life for many women. The ongoing refinement of treatment strategies, coupled with a focus on prevention, is crucial to achieving the ambitious goal set by Breast Cancer Now: to ensure that by 2050, everyone with breast cancer will live and live well.
The Global Burden and the Need for Collaboration
Claire Rowney, chief executive of Breast Cancer Now, described the study as a “stark reminder” of the devastating impact of breast cancer worldwide. “We’re determined to realise our bold ambition that by 2050, everyone with breast cancer will live and live well, and we’re accelerating progress through building global collaborations with researchers and funders, as together You can go further, faster to ensure that every woman, no matter where she lives, can access early diagnosis, effective treatment and the support she needs.”
Sophie Brooks, health information manager at Cancer Research UK, echoed this sentiment, emphasizing the importance of prevention. “These figures are a sad reminder of the heavy toll breast cancer continues to take on women around the world. Prevention remains a key way to reduce rates, with a significant number of cases globally linked to preventable factors like smoking, overweight and obesity, and alcohol.”
The findings from this global analysis serve as a critical call to action. Reducing the burden of breast cancer requires a multifaceted approach encompassing lifestyle modifications, increased awareness, improved access to screening and treatment, and sustained international collaboration. Further research is needed to fully understand the drivers of rising incidence, particularly among younger women, and to develop targeted prevention strategies.
The Global Burden of Disease Study Breast Cancer Collaborators will continue to monitor these trends and provide updated forecasts in the coming years. The next major update is anticipated in early 2027, offering a further assessment of progress and emerging challenges in the fight against breast cancer.
Have your own thoughts on this important research? Share your comments below, and please consider sharing this article to raise awareness about breast cancer prevention.
